<DOC>
	<DOCNO>NCT02655757</DOCNO>
	<brief_summary>This study investigate Effect Sitagliptin , dipeptidyl peptidase-4 inhibitor , Progression Coronary Intermediate Lesion .</brief_summary>
	<brief_title>Effect Sitagliptin Progression Coronary Intermediate Lesion</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients &gt; 18 , &lt; 80 year old , type 2 diabetes mellitus angiographically proven Coronary Intermediate Lesion . Allergy hypersensitivity drug 's component . Severe liver failure , moderate severe kidney failure Malignant disease . Active infectious disease . Pregnancy breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>